Balcoltra is owned by Avion Pharms.
Balcoltra contains Ethinyl Estradiol; Levonorgestrel.
Balcoltra has a total of 1 drug patent out of which 0 drug patents have expired.
Balcoltra was authorised for market use on 09 January, 2018.
Balcoltra is available in tablet;oral dosage forms.
Balcoltra can be used as administration of ferrous bisglycinate tablets.
The generics of Balcoltra are possible to be released after 01 June, 2027.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US7838042||AVION PHARMS||Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions|| |
(3 years from now)
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 09 January, 2018
Treatment: Administration of ferrous bisglycinate tablets
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic